Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. | Diabetes Care;21(5): 822-7, 1998 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.

Wieman, T J; Smiell, J M; Su, Y.

Affiliation

Wieman TJ; Department of Surgery, University of Louisville School of Medicine, Kentucky, USA.

Diabetes Care ; 21(5): 822-7, 1998 May.

Article in En | MEDLINE | ID: mdl-9589248

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Diabetic Foot / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 1998 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Diabetic Foot / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 1998 Document type: Article Affiliation country: